What's Next For Johnson & Johnson Stock?
Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.
Johnson & Johnson’s stock falls despite Q3 sales beat and guidance raise
Johnson & Johnson reported better-than-expected third-quarter sales and raised its full-year revenue guidance.
Rick Johnson, ex-Michigan House speaker, strikes out in bid to leave prison early
The denial was the latest loss for the LeRoy Republican convicted of receiving $110,000 in bribes & trysts with a sex worker ...
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...
FiercePharma18h
Johnson & Johnson sets 'new standard in inclusive marketing' with diverse Tremfya psoriasis ad
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
Deloitte, Johnson & Johnson execs say people aren’t using their health benefits until they are in crisis
“We should all care about health equity because that is one more person who is going to have a challenge to care for their ...
The Economist3m
Brandon Johnson is giving Chicago’s teachers’ union everything
L ast year, when he was campaigning to be mayor of Chicago, Brandon Johnson, a former organiser for the Chicago Teachers ...
Johnson & Johnson’s Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline
David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
NOLA.com2h
Yes, Flau'jae Johnson is WNBA draft-eligible. But the LSU star's focus lies elsewhere.
This season could be Flau'jae Johnson's last at LSU. Here's what the star junior thinks about her WNBA draft eligibility.
Michigan football DB Will Johnson 'definitely disappointed' with secondary
Naturally, much of the near 10-minute discussion was focused on the defense and its struggles. Just one year after leading ...
Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
Springfield man awarded $15 million after jury finds Johnson and Johnson liable for cancer diagnosis
A Springfield resident and local real estate entrepreneur, Evan Plotkin has just been awarded $15 million after a jury found ...